Table 6 Ancillary results
Group Variable n Baseline Week 8 p-value
KBA HAP MAS 7 76.4 (14.9) 77.7 (10.7) .77
HAP AAS 7 65.6 (18.4) 66.1 (13.5) .75
SEE POEE 7 4.2 (.5) 3.9 (.5) .18
SEE NOEE 7 2.5 (.5) 2.9 (.6) .17
Stability (0 – 5) 5 1.8 (.8) 2.4 (.6) .21
RT HAP MAS 8 69.0 (10.2) 67.5 (9.4) .64
HAP AAS 8 51.9 (9.2) 59.8 (11.6) .12
SEE POEE 8 3.8 (.7) 4.0 (.6) .26
SEE NOEE 8 2.6 (.9) 2.4 (.3) .44
Stability (0 – 5) 8 2.1 (1.0) 3.9 (.8) .01
KBA+RT HAP MAS 8 73.2 (14.5) 74.6 (10.1) .64
HAP AAS 8 56.8 (11.8) 62.0 (11.8) .19
SEE POEE 8 4.5 (.6) 4.5 (.6) .70
SEE NOEE 8 2.5 (1.1) 2.4 (1.0) .64
Stability (0 – 5) 7 3.3 (1.4) 3.7 (1.0) .35
Control HAP MAS 8 67.8 (11.7) 66.1 (12.6) .69
HAP AAS 8 50.9 (9.6) 52.5 (7.5) .50
SEE POEE 8 4.0 (.8) 4.3 (.7) .02
SEE NOEE 8 2.4 (1.0) 2.3 (.9) .35
Stability (0 – 5) 8 1.8 (.7) 2.8 (1.3) .03
HAP: Human Activity Profile, MAS: Maximum Activity Score, AAS: Adjusted Activity Score (both scales’ maximum = 94); SEE: Self-efficacy for Exercise, POEE: Positive Outcome Expectancy for Exercise (1-5 scale), NOEE: Negative Outcome Expectancy for Exercise (1-5 scale)